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Coronary artery bypass grafts and diagnosis
related groups: patient classification and hospital
reimbursement in 10 European countries
James Gaughan1*†, Conrad Kobel2,3† on behalf of the EuroDRG Group

Abstract
Background: The prospective reimbursement of hospitals through the grouping of patients into a finite number of
categories (Diagnosis Related Groups, DRGs), is common to many European countries. However, the specific
categories used vary greatly across countries, using different characteristics to define group boundaries and thus
those characteristics which result in different payments for treatment. In order to assist in the construction and
modification of national DRG systems, this study analyses the DRG systems of 10 European countries.
Aims: To compare the characteristics used to categorise patients receiving a coronary artery bypass graft (CABG)
surgery into DRGs. Further, to compare the structure into which DRGs are placed and the relative price paid for
patients across Europe.
Method: Patients with a procedure of CABG surgery are analysed from Austria, England, Estonia, Finland, France,
Germany, Ireland, Poland, Spain and Sweden. Diagrammatic algorithms of DRG structures are presented for each
country. The price in Euros of seven typical case vignettes, each made up of a set of a hypothetical patient’s
characteristics, is also analysed for each country. In order to enable comparisons across countries the simplest case
(index vignette) is taken as baseline and relative price levels are calculated for the other six vignettes, each
representing patients with different combinations of procedures and comorbidities.
Results: European DRG payment structures for CABG surgery vary in terms of the number of different DRGs used
and the types of distinctions which define patient categorisation. Based on the payments given to hospitals in
different countries, the most resource intensive patient, relative to the index vignette, ranges in magnitude from
1.37 in Poland to 2.82 in Ireland. There is also considerable variation in how much different systems pay for
particular circumstances, such as the occurrence of catheterisation or presence of comorbidity.
Conclusion: Past experience of the construction of DRG systems for CABG patients demonstrates the variety of
options available. It also highlights the importance of updating systems as frequently as possible, to incentivise
best practice.
Keywords: Diagnosis-related groups; DRGs; Hospital financing; Coronary artery bypass graft; CABG; Reimbursement
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Background

Clinical background

DRG background

Ischemic heart disease (IHD) is the most frequent cause
of death worldwide. In 2008, 12.8% of global deaths were
attributable to IHD and 15.6% in high income countries
[6]. Coronary artery bypass graft (CABG) surgery is
one of the two main surgical treatment options for IHD.
This revascularisation procedure diverts the flow of
blood around blocked or restricted vessels supplying
blood to the heart. Alternatives such as Percutaneous
Transluminal Coronary Angioplasty (PTCA), which
widens the restricted vessel, are generally preferred for
single vessel and anatomically uncomplicated cases [7,8].
On the other hand, CABG procedures are increasingly
performed on older and more moribund patients [9].
This trend suggests that the reimbursement of CABG
procedures in the context of other surgical procedures
such as valve replacements and the presence of comorbidities will become all the more critical as heterogeneity
of patients and the associated costs increase.

Diagnosis Related Group (DRG) systems use clinically
meaningful diagnostic and procedural characteristics to
categorise patients into a manageable number of resource homogenous groups. Each group is treated like a
product, so a hospital may be viewed as a firm producing multiple products [1]. While the original intention
behind DRGs was to develop a tool to measure resource
utilisation, DRGs soon became the foundation for a
number of applications [2]. One common use of DRGs
is as a reimbursement tool. Each group is assigned a
value, which reflects the average cost of patients within
the DRG [3]. This incentivises efficient use of resources
as excess payments are retained and costs paid by the
hospital [4]. DRGs are also used to measure hospital
performance, by removing the impact of case mix differences from observable outputs [5]. Finally, such a
reimbursement system can financially incentivise best
practice, by paying a higher price when additional resources are needed (in the form of tests, procedure
type or length of stay), but not doing so when such additions are not optimal. Thus, a major aim of DRG systems is forming group boundaries that are associated with
legitimate differences in cost/resource consumption when
the most appropriate treatment is used. Failure to adequately map reimbursement to legitimate cost, either
by attaching different reimbursement to patients of similar cost or by grouping patients with large differences to the same tariff, results in a mismatch between
the profit maximising treatment and the most appropriate treatment. Such a mismatch could result in patients
receiving inappropriate treatment or the provider of treatment being financially penalised for giving clinically optimal care.
Two case group types provide particular challenges in
constructing and maintaining a DRG system. First, more
complex cases with comorbidities have greater potential
heterogeneity, forcing a system to have a larger number
of sparsely populated DRGs or a smaller number of
more heterogeneous categories. Second, when advances
in medical research are faster, the ideal treatment approach changes more frequently. If a DRG system does
not keep pace with advances, it could restrict the dissemination of new approaches by financially incentivising outdated methods.
Determining characteristics accurately is most important when the budgetary impact of a subset of
DRGs is large, due to the average expense of cases
or the number of patients concerned. The cost of inaccuracy to performance and best practice is greatest in these cases. As such, regular updating of
DRG systems is vital for meeting the objectives of a
DRG system.

Our contribution

In this study, we analyse the differences in patient classification in ten European countries (Austria, England,
Estonia, Finland, France, Germany, Ireland, Poland,
Spain and Sweden)a and the outcome of this on reimbursement. The comparison of classification characteristics
is facilitated by seven hospitalisations for CABG surgery of
differing complexity (case vignettes), which also highlight
the impact of variation in the relative reimbursement of
these vignettes. This approach provides an overview of past
experience and some initial comparisons of variation in
approach upon the reimbursement of hospitals for the
treatment of patients requiring CABG surgery.
This work is performed within the framework of the
EuroDRGb project, which looks at hospitalisations for
ten conditions, analysing the ability of different DRG
systems to account for patient characteristics, as well as
analysing the impact of a variety of patient characteristics upon the cost or length of stay of patients [10,11].
In this article we focus on CABG surgery, as one of the
most frequently performed major surgical procedures
and a procedure with many variations in approach.

Methods
Data

Researchers obtained patient level data at national or regional level, containing core information on diagnoses,
procedures and DRG for each patient, in order to identify agreed conditions. A description of the sources of
data used is given in Table 1. From this core information, analysis is performed on two characteristics of
DRG systems. First, the structural nature of the DRG
system, highlighting the hierarchy of decision making
for patient classification. Second, the specific DRGs and
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Table 1 Sources of data
Country

Source of data

Year

Austria

Performance-oriented Hospital Financing
Framework Database

2008

Private Hospitals Financing Fund Database 2008
England

Hospital Episode Statistics (HES)

2007/08

National Health Service Reference Costs

2007/08

CHE Trust Database

2007/08

Estonia

Estonian Health Insurance Fund (EHIF)
Database

2008

Finland

Hospital Discharge Register
(hospitals of Helsinki and Uusimaa)

2008

France

National Hospital Cost Study
(ENCC; representative sample)

2007

Hospital Inpatient Activity Database
(PMSI MCO; all hospitals)

2008

Germany

Research database based on patientlevel data according to §21 Hospital
Remuneration Act (KHEntG) and national
G-DRG cost accounting standards by the
Institute for the Hospital Remuneration
System (InEK)

2008

Ireland

Hospital In-Patient Enquiry (HIPE)

2008

Poland

Central Register of Healthcare Services
and Reimbursements

2009

Spain (Catalonia) Public Hospital Network of Catalonia
Sweden

allocate a particular case to one DRG or another. A larger number of DRGs allows for a more nuanced allocation of patients at the expense of complexity and greater
potential for unintended incentives, where clinically and
financially optimal treatment diverges. Further, the presence or absence of any given characteristic in a DRG
structure generally represents the presence or absence of
a differential in reimbursement on the basis of that characteristic. Alternative approaches to reimbursement such
as surcharges are also discussed. Table 2 gives a summary of the characteristics used by different DRG systems to allocate cases to DRGs.
Second, the hierarchy of DRG structures are considered. The importance placed on a characteristic depends
upon its place in the overall structure and it is important
to note that not all structures are symmetrical. For example, catheterisation is a diagnostic test which may be
present in a structure. However, the impact and particularly incentives attached to this test would differ if it was
the first characteristic considered compared to a scenario where it is only considered for a subset of CABG
cases, such as less complex cases.
CABG case vignettes

2008

Spanish Network of Hospital Costs

2008/09

National Case Costing Database

2008

values assigned to a set of case vignettes, to investigate
the impact of variation in the allocation of patients and
values to DRGs upon reimbursement.
Patient classification systems

Within the EuroDRG project, we define a CABG case as
admission to hospital of a patient who undergoes a coronary artery bypass graft surgery (procedure code 36.1
in ICD-9-CMc). Patients aged under one year are excluded from the analysis. In order to compare structural
differences in patient classification, the CABG cases conforming to the definition described and the DRGs to
which these patients are categorised, is presented graphically in Figures 1 and 2. These figures show the grouping hierarchy and the final proportions of CABG cases
in each DRG. Analogously to the other works of the
EuroDRG project, particular attention is placed on
DRGs which contain more than 1% of CABG cases [11].
However, all DRGs which elucidate the overall structure
are also included, even if less than 1% of CABG cases
are assigned to them. In the figures, these DRGs are
marked with dashed lines, while the DRGs with the
highest proportion of CABG cases are highlighted bold.
DRG structures are considered in two ways. First, the
number of DRGs and specific characteristics used to

One of the major methodological issues which arises
when quantitatively comparing DRG systems across countries, is variation in purchasing power between nations.
Therefore, even after adjusting for currency differences,
some of the variation in observed price will be due to variation in the cost of labour and cost of living. Further, in
comparing DRG prices, there is variation in the parts of
cost included in a DRG tariff, see [12] for details. In order
to draw comparisons between countries, seven case vignettes are used. Of these, the simplest one is used as the
index vignette. The relative prices for all other vignettes
are calculated by dividing the absolute prices by the price
of the index vignette. So the relative price of the index vignette equals 1 for all countries.
The index vignette contains the simplest and most
prevalent CABG DRG in all ten European systems studied. The specific case is a 65 year old patient, who undergoes a bypass of a single vessel without any additional
procedures or any comorbidity. The length of stay (LoS) is
12 days. As such, all the relative prices calculated, compare to the DRG to which this case is allocated.
Vignette 1 involves a multiple vessel bypass (specifically 3 vessels) and the use of catheterisation on a patient,
also 10 years older than the index vignette. A valve procedure is performed along with CABG surgery, with the
use of catheterisation, in case vignette 2. This patient
also has a shorter LoS than the index vignette at nine
days and the stay ends in death. Vignette 3 is most similar to vignette 1, with an additional three days of LoS
and diagnoses of diabetes, dilated cardiomyopathy and
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Figure 1 Grouping structure.
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Figure 2 Grouping structure.

cerebral infarction (Stroke). Vignette 4 combines multiple vessel bypass with a valve procedure but without
catheterisation. The patient also has chronic renal failure. Vignette 4 also has a longer LoS than the index
vignette (18 days). Vignette 5 includes a secondary diagnosis with valve procedure and catheterisation. The diagnosis is of atrial fibrillation. This patient has the longest
LoS at 20 days. Finally, vignette 6 involves the same procedures as vignette 4, performed on a 75 year old patient, also diagnosed with acute transmural myocardial
infarction of anterior wall. Another distinguishing feature of this vignette is that the case ends in death
after a two day inpatient stay. The definition of the vignettes given in ICD-9-CM and ICD-10d are presented
in Table 3.

The value of a DRG is either its assigned cost weight
or price, depending on the particular DRG system [3].
Where DRGs are attached to weights (Estonia, Finland,
Germany, Ireland Spain and Sweden) or scores (Austria
and Poland), rather than prices (England and France),
national conversion systems to reflect average cost of
the DRG are used. The reimbursement price of each vignette is then divided by the reimbursement price for
the index vignette. This provides the relative value placed
on each vignette by each DRG system, compared to the
index vignette. However, it should be noted here that as
DRGs represent average price and are of varying sizes, so
are the values attached to the index vignette, as that of the
DRG to which the index vignette is assigned, retains that
variability.
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Table 2 DRG split variables
Country

Age

LoS

Comorbidities/complications

Catheterisation

Valve procedure

Death

First CABG

Austria

---

---

x

---

x

---

---

England

---

---

---

x

x

---

x

Estonia

---

---

---

x

x

---

---

Finland

---

---

x

x

x

---

---

France

---

x

x

x

---

x

---

Germany

x

---

x

x

---

---

---

Ireland

---

---

x

---

---

---

---

Poland

---

---

x

---

---

---

---

Spain

---

---

x

x

x

---

---

Sweden

---

---

x

x

x

---

---

Source: [10] Table 1.

From this process, two closely related features are considered across countries. First, the DRG to which each
vignette is allocated. This serves to highlight the impact
of the choice of different characteristics to define DRGs
and the hierarchy of those characteristics. Such differences result in some different cases being treated as the
same in some systems but not others.
Second, the specific relative reimbursement levels for
the same vignette are considered. This shows the different
levels of importance placed on particular characteristics
between systems and within them, since the same characteristic may result in a different change in reimbursement
in different scenarios. Considering relative reimbursement
also directly accounts for adjustments made in payment
that are not through a change of DRG. This is important
as it is final reimbursement which drives incentives, rather
than a DRG allocation.

Results
Grouping hierarchy

Figures 1 and 2 highlight differences in the number and
types of characteristics used to group patients, as well as
the degree of division within each. Differences exist in
the number of DRGs used to categorise CABG cases.
This ranges from two (Poland) to 16 (France), with the
majority of systems analysed having between four and
eight groups. There is also variation in the concentration
of patients within DRGs. The proportion of CABG cases
in the most populous DRG category of each country
ranges from 24% (France) to 85% (England) and the total
proportion of CABG patients covered by DRGs containing at least 1% of the total sample ranges from 92%
(Germany) to 100% (Ireland). For better comparison, the
presentation of the grouping hierarchy and the terms
used to describe DRGs are to some extent harmonised.

Table 3 Case vignette specifications
ICD-9-CM
procedure codes

Vessels

Primary
diagnosis

Secondary
diagnoses

Catherisation

Valve
surgery

Age

Death during
admission

LoS

Index

36.11

1

I25.1

---

No

No

65

No

12

Case 1

36.13

3

I25.1

---

Yes

No

75

No

12

Case 2

36.11

1

I25.1

---

Yes

Yes

65

Yes

9

Case 3

36.11

1

I25.1

E11.8, I42.0, I69.3

Yes

No

75

No

15

Case 4

36.13

3

I25.1

N18.0

No

Yes

65

No

18

Case 5

36.11

1

I25.1

I48

Yes

Yes

75

No

20

Case 6

36.13

3

I35.0

I21.0

No

Yes

75

Yes

2

Notes:
I25.1 - Atherosclerotic heart disease.
I35.0 - Aortic (valve) stenosis.
E11.8 - Non-insulin-dependent diabetes mellitus with unspecified complications.
I10.0 - Essential (primary) hypertension.
I21.0 - Acute transmural myocardial infarction of anterior wall.
I42.0 - Dilated cardiomyopathy.
I48 - Atrial fibrillation and flutter.
I69.3 - Sequelae of cerebral infarction.
N18.0 - Chronic renal failure: End-stage renal disease.
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Generally the grouping process follows the same steps
across the studied systems. The patient’s principal diagnosis determines the Major Diagnostic Category (MDC)e,
except in Austria where no such concept is used. The
MDC for our CABG cases concerns the circulatory system, except in Germany, Ireland and Spain, where some
extreme resource consuming cases (long-lasting mechanical ventilation) are grouped into the Pre-MDC, designed
for this purpose.
The second step includes the decision whether the
treatment is considered a surgery, sometimes also called
operating room (OR) procedure, or if the treatment is
not. All CABG cases are considered as surgery and hence
are grouped into the corresponding partition. Only the
Polish system does not make this distinction.
Next, the actual treatments become relevant. Generally, the systems distinguish between two different scenarios. The first is a valve surgery together with a CABG
during the same hospitalisation. In this case, the valve
surgery becomes the dominant grouping criteria. The
second scenario is a “classical” CABG surgery (without
valve surgery). Especially in the latter case, systems further
differentiate the types of CABGs, e.g. first (England), multiple (Austria) or complex (Austria and Germany) CABGs.
Additional accompanying treatments are used as split
variables in a number of countries such as cardiac
catheterisation (England, Estonia, Finland, France, Ireland,
Germany and Spain), the most frequently used characteristic for CABG cases.
To determine the severity of a case, “Complications or
Comorbidities” (CC) based on secondary diagnoses are
used as grouping criteria in some countries (Finland,
France, Poland, Spain and Sweden). This ranges from a
single dichotomy of CCs in Poland, Finland and Sweden
to four levels of CCs in France. In Ireland, a so-called
Patient Clinical Complexity Level (PCCL) is used to determine the cumulative effect of all diagnoses reported for a
particular patient. Instead of CCs, in Germany the primary
diagnosis Acute Myocardial Infarction (AMI) is used in
one part of the structure. Instead or in addition to CC
splits, other criteria can be used as well. Age is used in
Austria, Germany and Poland. Length of stay, particularly
as a cut off value, or whether a patient dies in hospital
determines the DRG in France; and in Finland, the type of
admission is used once. It will be seen below that while
each DRG has an attached reimbursement, it is not always
the only determinant of reimbursement. Most commonly,
reductions or surcharges apply on a per diem basis for
short-stay or long-stay outliers.
Case vignettes

Figure 3 graphs the relative prices of each DRG, compared to the index vignette for the relevant country. The
price paid for each DRG for each country studied, is

Page 7 of 13

given in Table 4. The names and codes of the DRG each
vignette is mapped to, is presented in Additional file 1.
Vignette 1

The additional price for case vignette 1, relative to the
index vignette, ranges from 0 (Finland) to 59% (Estonia).
In all nations included, with the exceptions of Austria
and Poland, patients are grouped based on the occurrence of catheterisation. The Austrian system uses multiple vessels bypassed as a classification variable, though
not the use of catheterisation. However, this system includes an additional payment when catheterisation is
used. The Polish DRG system does not provide additional payments when catheterisation is used or multiple vessels bypassed. However, an additional 6% is paid
if the patient is aged over 69. In Finland, the index vignette and vignette 1 are categorised to different DRGs.
However, the difference in reimbursement is minimal
(0.002%).
Vignette 2

The proportional difference in reimbursement given to
vignette 2, relative to the index vignette, ranges from
23% (Poland) to 76% (Ireland). All systems analysed,
with the exception of the Estonian, place patients who
undergo a valve procedure into a different DRG to those
who do not. As noted above, in Estonia, classification
differentiates for the use of catheterisation. As such, vignette 1 and 2 are grouped together. The English system
categorises valve procedure patients into a broad category of “complex cardiac surgery”, rather than a CABG
specific category. The lower relative value of vignette 2
(24%) to vignette 1 (42%), suggests the average cost of
this broader group is lower than CABG specific groups.
This highlights the sort of disparities which can arise
when a small number of DRGs are used to classify heterogeneous patients. In general, a higher tariff is paid for
patients undergoing valve procedure with a CABG than
catheterisation alone (vignette 1), with the highest tariffs
paid by systems which reimburse based on catheterisation and valve procedures (Austria, France, Germany,
Ireland and Spain). The French case is slightly unusual
as it is the only system analysed which makes some explicit adjustment in tariff for patient death, grouping
these with cardiac patients with < 4 days stay in hospital.
Vignette 3

The relative price given to case vignette 3, compared to
the index vignette, ranges from 6% (Poland) to 103%
(Ireland). England, Estonia, Germany and Poland all group
vignettes 1 and 3 into the same DRG. The grouping of
these patients into the same category is due to these systems not using secondary diagnoses as a split variable or,
in the Polish case, not adjusting for comorbidities in
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Figure 3 Relative reimbursement of case vignettes.

patients aged over 70. In both vignettes 1 and 3, patient
age is 75. This structural distinction of inclusion or
exclusion of comorbidities as a split variable, may
partially account for the relatively high premium given in
England and Estonia (42% and 59% respectively) for patients with CABG and catheterisation. As comorbidities are expected to increase the cost of treatment, if
catheterisation is an indication of greater complexity,
patients with comorbidities will be more likely to receive catheterisation than those without. Therefore,
the average price of vignettes involving catheterisation
will be proportionally larger than the group without catheterisation. If, on the other hand, comorbidities are themselves split variables as well as catheterisation, the increase
for catheterisation without comorbidities can be expected
to be lower. The most complex cases would not be in
this group.
However, it should be noted that a small number of
broad categories, doesn’t necessarily result in large

differences for catheterisation specifically. The Polish system makes no adjustment for catheterisation and increases reimbursement by 6% on the grounds of age
alone. Other drivers of such a difference are the relative
homogeneity of the index DRG and the total expected
cost range of CABG procedure cases. In Austria and
Sweden, a lower tariff is paid for vignette 3 than vignette
1. The critical distinction for the Austrian system is that
in vignette 3, a single vessel is bypassed, rather than three
in vignette 1. This indicates the Austrian system provides
higher reimbursement for multiple vessel bypasses than
for secondary diagnoses. By contrast, the Swedish system
categorises vignette 3 into a DRG involving bypass and comorbidities, though without catheterisation, indicating
catheterisation is of greater weight in that system. In the
remaining four countries analysed, a higher tariff is paid
for vignette 3 than vignette 1, categorising vignette 3 into
a DRG involving comorbidities and providing at least 37%
higher tariff than the index vignette.

Index case

Patient 1

Patient 2

Patient 3

Patient 4

Patient 5

Patient 6

Austria1

England 2

Estonia3

Finland4

France5

Germany6

Ireland7

Poland

Spain8

Sweden9

DRG

Mel08.02C

EA14Z

107

107A

05C051

F32Z

F06B

E06

109

107A

Price (in €)

8,770

12,157

7,459

11,203

10,430

10,761

20,563

4,526

14,421

13,575

DRG

Mel08.02A

EA15Z

106

107B

05C041

F23Z

F05B

E05

107

107B

Price (in €)

11,479

17,279

11,857

11,227

12,140

13,079

28,391

4,797

19,836

18,253

Relative value

1.31

1.42

1.59

1.00

1.16

1.22

1.38

1.06

1.38

1.34

DRG

Mel08.03A

EA20Z

106

104A

05C022

F11A

F03Z (Outlier)

E22

104

104A

Price (in €)

14,908

15,041

11,857

15,109

16,445

17,867

36,184

5,575

22,070

17,798

Relative value

1.70

1.24

1.59

1.35

1.58

1.66

1.76

1.23

1.53

1.31

DRG

Mel08.02C

EA15Z

106

107C

05C042

F23Z

F05A

E05

546

107C

Price (in €)

9,396

17,279

11,857

16,531

14,337

13,079

41,648

4,797

25,060

16,570

Relative value

1.07

1.42

1.59

1.48

1.37

1.22

2.03

1.06

1.74

1.22

DRG

Mel08.03A

EA20Z

105

104B

05C031

F11B

F04B

E22

105

104B

Price (in €)

14,282

15,041

8,551

21,116

12,654

15,380

24,947

6,070

16,399

23,984

Relative value

1.63

1.24

1.15

1.88

1.21

1.43

1.21

1.34

1.14

1.77

DRG

Mel08.03A

EA20Z

106

104B

05C022

F11A

F03Z

E22

104

104B

Price (in €)

14,908

15,041

11,857

21,116

16,445

17,867

57,879

6,211

22,070

23,984

Relative value

1.70

1.24

1.59

1.88

1.58

1.66

2.81

1.37

1.53

1.77

DRG

Mel08.03A (Outlier)

EA20Z

108

104B

05C031

F11B (Outlier)

F04B (Outlier)

E22

545

104B

Price (in €)

10,143

15,041

5,268

21,116

12,654

10,890

14,365

5,575

30,433

23,984

Relative value

1.16

1.24

0.71

1.88

1.21

1.01

0.70

1.23

2.11

1.77
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1) Reported values are based on theoretically calculated scores. Actual hospital payment depends on decisions of states, which make use of nationwide DRG scores in different ways.
2) Based on 2008/9 tariff prices and HRG version 3.5. All relevant to-ups are included in the shown tariff. HRG 4 payments could not be determined. Reported figures are a weighted average of payments for elective
and emergency admissions, using the ratio of elective and emergency cases in the study period. Elective admissions receive a different tariff from elective cases in many DRGs.
3) Shadow prices were calculated by multiplying cost weights with the national base rates. In actual payment, hospitals are paid through a mix of DRG based payment and fee-for-service. The actual DRG based
payment is only 70% of the reported shadow price with the remaining 30% being related to fee-for-service payments.
4) Actual payment varies by type of hospital (i.e. University, central, local hospitals) and hospital district. Provided figures are volume weighted averages across all hospitals. Outlier limits differ between hospital
districts. In some hospital districts, patient 3 might be considered an outlier. In this case certain surcharges based on per diems might be applied.
5) Reported prices are for public sector hospitals since private hospital prices do not reflect full costs.
6) Calculated using national DRG cost weights and the average of state-wide base rates (2803.05 €).
7) Calculated using AR-DRG V 5.1 and the national average inpatient 'base price' of €5,219 for a relative value of 1 and the other casemix parameters (including low and high length of stay trim points) from the 2009
inpatient casemix model (used to estimate the 2010 casemix budgetary adjustments on the basis of 2008 activity and cost data).
8) AP-DRGs in Spain are used when patients receive care in non-resident autonomous communities (ACs). The prices shown are the rate that would be paid for these patients, calculated by multiplying national
Spanish cost weights with the national base rate. The payment to hospitals for all other patients depends on the hospital payment system in the relevant autonomous community. When using AP-DRGs in Spain,
inliers/outliers are not determined.
9) Actual hospital payment depends on the county council, which is free to decide how to pay hospitals.
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Table 4 Vignette prices
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Vignettes 4 and 5

Additional reimbursement for case vignette 4, relative
to the index vignette, ranges from 14% (Spain) to 88%
(Finland). The increase in reimbursement for vignette 5
ranges from 24% (England) to 181% (Ireland). A comparison between the payments given for case vignettes 2,
4 and 5 illustrates the variety of approaches with respect
to the payment for catheterisation, and secondary diagnoses, in the presence of valve procedures. In England
and Austria, all three vignettes are grouped into the
same DRG, indicating that when a valve procedure is
performed, the occurrence of catheterisation or comorbidities does not impact on DRG. As noted above, the
Austrian system uses a surcharge to increase a tariff
which involves catheterisation. So though the DRG of all
the patients is the same, the payment for patients 2
and 5 is higher than patient 4. The Estonian, French,
German and Spanish systems pay for catheterisation but
not for atrial fibrillation as a secondary diagnosis, grouping vignettes 2 and 5 into a common higher DRG than
vignette 4. In Finland and Sweden, a higher tariff is paid
in the presence of secondary diagnoses and this tariff is
the same with or without catheterisation, grouping vignettes 4 and 5 into a common higher tariffed DRG than
vignette 2. In Ireland and Poland, a higher tariff is paid
for vignette 5 than either vignette 2 or 4. However, they
differ in that the Polish system pays a higher tariff in the
case of comorbidities, with or without catheterisation,
while the Irish system puts greater value on the presence
of catheterisation in calculating reimbursement, while
making a smaller adjustment for the case of comorbidities in the absence of catheterisation.
Vignette 6

The change in reimbursement for case vignette 6, relative to the index vignette, ranges from −30% (Ireland)
to +111% (Spain). Patient 6 combines a relatively complicated case with a short length of stay which ends in
death. English, Finnish, French and Swedish systems, place
vignette 6 into the same DRG and pay the same amount
for this patient as vignette 4. In Austria, Germany, Ireland
and Poland, vignettes 4 and 6 are grouped into the same
DRG, but pay a lower amount for vignette 6, categorising
it as a short stay outlier. As such, this difference in reimbursement is driven by the length of stay rather than the
final outcome. However, where death occurs after a CABG
procedure, it is also correlated with a relatively short LoS.
Therefore, the lower reimbursement may represent an implicit penalty for cases ending in death. The Estonian and
Spanish systems place vignette 6 into a different DRG
than vignette 4. In Estonia, a lower payment is given for
vignette 6. This is driven by diagnosis rather than the
presence of death. Also in Spain there is no adjustment
for the case of death but a higher tariff is paid to account
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for the complexity of the case, categorising the patient
into a major CC DRG. It is noteworthy from this vignette
that while only France explicitly categorises patients based
on outcome, where occurrence of death is associated with
a short LoS, a short stay outlier can simultaneously represent a lower payment for less complex patients and the
same reduction for patients who died in hospital as a penalty for poor outcome.

Discussion
The definition of patient categories and their weights are
two major sets of decisions made in the construction or
updating of a DRG system. This study presents the degree of variation in past choices made across Europe.
The analysis reveals the wide variation that persists in
the number of categories patients are grouped into. It
should also be noted that having a larger number of
groups does not necessarily result in a more accurate reflection of the variation in cost of CABG patients [10],
the variation in the particular variables used to define
the boundaries of DRGs and how these are hierarchically
structured is also important. The decision as to the
weight attached to particular variables is also explored,
drawing particular attention to the different ways that
the same characteristic can be dealt with and the impact this has on reimbursement. However, while highlighting some of the most important decisions and options
in the DRG construction process, not all decisions are
covered.
The Austrian system attributes CABG cases to six
DRGs, notably adjusting for multiple vessel bypass as
well as valve procedure. Of these, valve procedures carry
a higher reimbursement. The age split is not picked up
by the case vignettes as it applies to patients younger
(and older) than 14. This distinction is only used for the
simpler CABG procedures without valve procedures or
multiple vessel bypass. Alongside this DRG structure,
there are supplementary payment mechanisms for the
presence of catheterisation and for shorter length of stay.
As a result, four of the case vignettes are grouped to the
same DRG but three different reimbursement levels are
paid.
The English system has the highest concentration of
patients in a single DRG at 85%. Also, the vignettes are
grouped into the smallest number of DRGs (three). The
critical feature of this system is the distinction between a
“First CABG” and “Other Complex Cardiac Surgery and
Redos”. This set of DRGs acts in a similar way to valve
procedure DRGs in other systems, as patients who receive a valve procedure are grouped to this set of DRGs.
However, it is not identical as though there is a separate
DRG for complex cardiac surgery and redos with catheterisation, cases with valve replacement do not fall into
this category. Another feature of this system is that the
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reimbursement level for catheterisation (1.42) is higher
than that for valve procedure (1.24) potentially due to
the broader DRG of complex cardiac surgery including
some less complex cases, thus reducing its average cost.
In Estonia, CABG patients are grouped into four
DRGs. Both catheterisation and valve procedure are used
to group patients. CABG and valve procedure are treated separately in the structure with catheterisation as a
secondary split for CABG procedures. The case vignettes
indicate the presence of catheterisation dominates that
of valve procedure in determining DRG as patients are
only grouped to the valve DRG in the absence of catheterisation. Also, a higher reimbursement level is given
for catheterisation (1.59) than valve procedures (1.16).
The separate diagnosis of aortic (valve stenosis) used in
vignette 6 also proves significant as this patient is allocated to a separate, lower reimbursed (0.71) DRG.
Finland and Sweden use the same NordDRG structure.
This system also separates cases of CABG and valve procedure but in both cases allocates to DRG based on the
presence or absence of comorbidities as well as catheterisation. These systems treat valve procedure as the
dominant characteristic, grouping all patients with that
procedure outside the DRGs for CABG alone and making separate adjustment for complications and not catheterisation. It is also noteworthy that even though the
same NordDRG system is used, reimbursement is not identical. In most cases, relative reimbursement levels are higher
in Finland than in Sweden. However, when catheterisation
is present in the absence of complications or valve procedure, the Swedish system increases reimbursement by 34%
compared to less than 1% in Finland.
The French DRG system uses the largest number of
groups (sixteen) for CABG cases. The principal division is
between CABG and valve procedures, as it is in several systems. Cases involving a valve procedure are grouped outside the set for CABG and further adjustment is made for
the use of catheterisation and the presence of comorbidities at different levels. LoS and cases of death are
attributed to specific comorbidity levels within each set of
these. This approach allows for maximum flexibility as a
different level of reimbursement can be given for the same
procedure (such as catheterisation) in different circumstances (CABG or valve replacement) instead of giving an
average price for all cases or only making an adjustment in
a subset of cases. As such, there are separate reimbursement levels for catheterisation, valve procedure and the
two combined (at 1.16, 1.26 and 1.59 respectively). The differential cost of comorbidities is also accounted for in
some cases, as in comparing vignettes 1 and 3 but not all,
as in comparing vignettes 2 and 5.
CABG patients are grouped into three DRGs in the Polish system. The first distinction is between percutaneous
valvuloplasty and CABG. Within the CABG groups, a
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further distinction is made between presence or absence of
comorbidities for patients aged 69 and younger. All vignettes including a valve procedure are grouped to the valvuloplasty. In the remaining two vignettes, the additional
6% are paid to account for patient age being 75.
The Irish DRG system groups CABG patients into
eight DRGs. The structure is similar to the French, adjusting for the same characteristics and hierarchy. However, only a dichotomy of comorbidity is used and no
adjustment is made for catheterisation in the case of
valve procedure, though it is if valve procedure is absent.
Further, there is an additional DRG for extreme cases in
the separate Pre-MDC. Similar to the French system,
the use of comorbidities as additional splits within
CABG or valve procedure, allows for nuanced reimbursement. For example, a CABG with catheterisation
and without valve procedure receives a reimbursement of 1.38 without comorbidities and 2.03 in the
presence of sufficient comorbidities or complexity. Further, in the presence of valve procedure and catheterisation, reimbursement is 1.76 in the absence of
comorbidities and 2.81 when present.
Cases of CABG in Germany are grouped into 14
DRGs. Besides DRGs in the Pre-MDC for extreme
cases, as in the Irish system, DRGs are split into three
main groups of interest. These are CABG, valve procedures and CABG with complex procedures. All vignettes
including valve procedures are grouped to a valve category, indicating this dominates the presence of CABG.
There is a further subdivision for the use of catheterisation, shown by the payment of 1.66 for vignette 2 and 5
compared to 1.43 for vignette 3. The lower payment of
1.01 for vignette 6 is driven by its short length of stay,
showing an outlier adjustment. The equal payment made
to vignette 1 and 3 at 1.22, shows the adjustment made
for the presence of catheterisation in the absence of valve
procedure and that there is no further adjustment for comorbidities in this case.
Finally, the Spanish DRG system groups CABG cases
into nine DRGs. Here again a Pre-MDC for extreme
cases is used. The first consideration in the main system
is between the presence or absence of major comorbidities. Among the case vignettes, vignettes 4 and 6 fall into
this category. The distinction between CABG and valve
procedure is then used and at last catheterisation. This
results in the highest reimbursement being paid for cases considered to include major comorbidities and then
a further addition where catheterisation is used, specifically 1.74 for vignette 4 and 2.11 for vignette 6. The other
four vignettes show a similar level of flexibility in reimbursement for catheterisation (1.38), valve procedure
(1.14) or the procedures together (1.53). It is noteworthy
that valve procedures receive a smaller increase in reimbursement than catheterisation.
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Through case vignette comparisons, this study draws attention to some of the most frequent characteristics used to
define DRG boundaries, namely catheterisation, valve procedures and complications. This is not an exhaustive list of
the characteristics considered, as shown in the description
of patient classification. As such, there is no quantitative
comparison of the reimbursement paid for less frequently
used characteristics such as the diagnosis of AMI. While
these less common characteristics are also of importance,
they are less suited for international comparison, as most
systems do not differentiate between their presence and
absence. Further, the method for paying for extreme outliers is not presented in graphical or numerical analysis.
However, this decision is also of critical importance.
The comparison of magnitudes also has limitations. A
major obstacle to any cross country comparison is the
difference in the purchasing power of currency across
nations. By analysing the proportional impact on price
of different case vignettes on a common index vignette
within each country, this study removes this problem to
some extent. However, this approach mitigates, but does
not remove, the degree to which different cost categories
are accounted for in respective DRG systems. The relative price of a DRG would be exaggerated if the DRG
system only pays for variable cost. If instead, some element of fixed cost is included in the tariff, variation will
shrink and the value placed on a particular characteristic
appear smaller.
Additions within the DRG systems, such as surcharges
in Austria for catheterisation, are included in the comparison. However, several idiosyncrasies are not adjusted for
in absolute prices. These include adjustments for different
regions in England, the summation of multiple DRGs in
Finland, and possible separate per diem rates for stays in
intensive care units in Austria [13] and Poland [14].
Also, the use of relative difference does not diminish
the impact of different coding methods across countries.
This is of particular significance in payments for procedures, where common ICD-9-CM codes are mapped to
national systems [11]. A national coding system for procedures may also inform the structure of national DRGs.
Finally, this study does not consider the relationship
between DRG tariff and the actual cost of a patient.
While a DRG system is generally based on past costs of
patients, each category groups a set of ultimately unique
patients and provides a payment based on some average
cost of these. Therefore, the vignette cases serve as examples of different scenarios and the tariff paid for them
may not reflect the cost of treatment.

Conclusions
Despite the limitations of comparing magnitudes across
countries, this study highlights the size and complexity of
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variations between DRG systems across Europe. The decisions which go to make up these systems are of critical importance to clinicians and policy makers. The construction
of a DRG system which accurately reflects the cost of best
practice, aligns the aims of both sets of stakeholders, and
requires the expertise of both to be created and sustained
as practice is changed by new findings and innovations.
Failure to align these incentives can lead to conflict between
the two sets of stakeholders. If the reimbursement for best
practice is insufficient to cover its cost or reimbursement
for an outdated treatment approach remains the highest
available, the patient is liable to receive sub optimal care as
the provider is incentivised to maximise revenue.
Whether the variations discussed above are symptomatic of variation in national epidemiological or technological circumstance or the expediency of a DRG system
is not the question answered here. Instead, this study
presents a set of approaches which have been taken in
the past and follows them to their impact upon reimbursement. Without providing evidence as to the optimal structure, the information can be used to suggest
alternative approaches that may better align clinical and
financial incentives in future system designs or updates. The potential for variation in decisions demonstrates the importance of careful consideration in DRG
construction.

Endnotes
a
Strictly speaking, in Austria, England and Poland
grouping is performed using Patient Classification Systems that are less diagnosis-related. However, for convenience and readability we will refer to all systems as
DRG systems.
b
For details regarding the EuroDRG project see http://
eurodrg.projects.tu-berlin.de/wiki/doku.php?id=start.
c
International Classification of Disease 9th edition,
clinical modification.
d
International Statistical Classification of Diseases and
Related Health Problems, 10th Revision.
e
In England and Poland these categories are called
Chapters.
Additional file
Additional file 1: Vignette names codes.
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